Abstract
Rheumatoid arthritis is associated with high disease activity and multiple comorbidities that may negatively impact the patient’s quality of life (QOL). Furthermore, the presence of complex drug regimens and polypharmacy raises the risk of medication non-adherence. Hence, we aimed to assess the impact of clinical pharmacist interventions on patients' QOL and medication adherence among rheumatoid arthritis patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
